GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » Shiller PE Ratio

Dr. Lal PathLabs (NSE:LALPATHLAB) Shiller PE Ratio : 78.58 (As of May. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Shiller PE Ratio?

As of today (2024-05-28), Dr. Lal PathLabs's current share price is ₹2632.35. Dr. Lal PathLabs's E10 for the quarter that ended in Mar. 2024 was ₹33.50. Dr. Lal PathLabs's Shiller PE Ratio for today is 78.58.

The historical rank and industry rank for Dr. Lal PathLabs's Shiller PE Ratio or its related term are showing as below:

NSE:LALPATHLAB' s Shiller PE Ratio Range Over the Past 10 Years
Min: 60.76   Med: 73.72   Max: 83.6
Current: 78.4

During the past years, Dr. Lal PathLabs's highest Shiller PE Ratio was 83.60. The lowest was 60.76. And the median was 73.72.

NSE:LALPATHLAB's Shiller PE Ratio is ranked worse than
86.25% of 80 companies
in the Medical Diagnostics & Research industry
Industry Median: 28.78 vs NSE:LALPATHLAB: 78.40

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Dr. Lal PathLabs's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹10.170. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹33.50 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Dr. Lal PathLabs Shiller PE Ratio Historical Data

The historical data trend for Dr. Lal PathLabs's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Shiller PE Ratio Chart

Dr. Lal PathLabs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 67.55

Dr. Lal PathLabs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 76.94 77.45 67.55

Competitive Comparison of Dr. Lal PathLabs's Shiller PE Ratio

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Lal PathLabs's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Shiller PE Ratio falls into.



Dr. Lal PathLabs Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dr. Lal PathLabs's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=2632.35/33.5
=78.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Lal PathLabs's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Dr. Lal PathLabs's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.17/153.0345*153.0345
=10.170

Current CPI (Mar. 2024) = 153.0345.

Dr. Lal PathLabs Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201412 2.770 96.780 4.380
201503 3.470 97.163 5.465
201506 3.720 99.841 5.702
201509 0.750 101.753 1.128
201512 7.310 102.901 10.871
201603 4.140 102.518 6.180
201606 4.850 105.961 7.005
201609 6.430 105.961 9.287
201612 3.750 105.196 5.455
201703 3.840 105.196 5.586
201706 5.400 107.109 7.715
201709 6.180 109.021 8.675
201712 4.390 109.404 6.141
201803 4.870 109.786 6.788
201806 6.000 111.317 8.249
201809 6.900 115.142 9.171
201812 5.550 115.142 7.376
201903 5.700 118.202 7.380
201906 7.130 120.880 9.027
201909 9.750 123.175 12.114
201912 6.550 126.235 7.941
202003 3.940 124.705 4.835
202006 3.440 127.000 4.145
202009 10.310 130.118 12.126
202012 11.410 130.889 13.340
202103 10.090 131.771 11.718
202106 15.840 134.084 18.079
202109 11.450 135.847 12.899
202112 6.900 138.161 7.643
202203 7.420 138.822 8.180
202206 6.960 142.347 7.483
202209 8.600 144.661 9.098
202212 6.330 145.763 6.646
202303 6.820 146.865 7.107
202306 9.930 150.280 10.112
202309 13.120 151.492 13.254
202312 9.760 152.924 9.767
202403 10.170 153.035 10.170

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dr. Lal PathLabs  (NSE:LALPATHLAB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Dr. Lal PathLabs Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Traded in Other Exchanges
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines